Assessing efficacy and safety of CAR T-cell therapies

Dr. James Keck, Senior Director for Innovation and Product Development at The Jackson Laboratory, presents a novel PBMC humanized mouse model to assess efficacy and safety of CAR T-cell Therapy. He covers basic experimental design, toxicity and efficacy, cytokine induction, and more.

This video was filmed in partnership with The Jackson Laboratory.